Thrombectomy Devices Market Size, Share, Industry Trends and Forecast to 2030

Thrombectomy Devices Market Size & CAGR in 2021

The global thrombectomy devices market is expected to have a growth rate of 5.2% CAGR from 2021 to 2025. The market size is anticipated to reach USD 1.5 billion by 2025.

COVID-19 Impact on the Thrombectomy Devices Market

The COVID-19 pandemic has had a significant impact on the thrombectomy devices market. Due to the outbreak of the virus, there was a disruption in the supply chain, leading to a decrease in the production of thrombectomy devices. However, with the increase in cases of thrombotic events in COVID-19 patients, there has been a surge in the demand for thrombectomy devices, driving market growth.

Thrombectomy Devices Dynamics

The thrombectomy devices market is driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements in thrombectomy devices, and the growing aging population. Moreover, the rising awareness about the benefits of minimally invasive procedures for thrombectomy is propelling market growth.

Segments and Related Analysis

The thrombectomy devices market can be segmented based on product type, end-user, and region. Product types include aspiration thrombectomy devices, mechanical thrombectomy devices, and rheolytic thrombectomy devices. End-users of these devices include hospitals, ambulatory surgical centers, and specialty clinics.

By Region Analysis

The thrombectomy devices market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America leads the market due to the presence of well-established healthcare infrastructure and the high adoption rate of advanced medical technologies.

Key Market Players and Competitive Landscape

Key players in the thrombectomy devices market include Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, and Terumo Corporation. These companies are focused on product innovation, strategic partnerships, and mergers & acquisitions to maintain their market position.

Recent Happenings in the Thrombectomy Devices Market

In recent developments, Medtronic launched the Solitaire X Revascularization Device for the treatment of acute ischemic stroke. Stryker Corporation announced the acquisition of NeuroVasc, a company specializing in neurovascular devices. Boston Scientific Corporation introduced the EXPLORER XT Microcatheter for accessing and navigating peripheral and coronary arteries.